Shareholdings
| Concept |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2019-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
As at 2018-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholdings | ||||||||||||
| Second largest holding company | ||||||||||||
| Details of specified investment shares held for purposes other than pure investment | ||||||||||||
| Issue |
第一三共㈱
|
持田製薬㈱
|
大塚ホールディングス㈱
|
久光製薬㈱
|
エーザイ㈱
|
東邦ホールディングス㈱
|
— | — | — | — | — | — |
| Number of shares |
53,680
xbrli:shares
|
40,000
xbrli:shares
|
1,600,000
xbrli:shares
|
70,334
xbrli:shares
|
287,435
xbrli:shares
|
120,000
xbrli:shares
|
287,250
xbrli:shares
|
68,415
xbrli:shares
|
53,680
xbrli:shares
|
120,000
xbrli:shares
|
1,600,000
xbrli:shares
|
20,000
xbrli:shares
|
| Carrying amount |
273,000,000
JPY
|
227,000,000
JPY
|
6,958,000,000
JPY
|
358,000,000
JPY
|
1,785,000,000
JPY
|
331,000,000
JPY
|
1,947,000,000
JPY
|
563,000,000
JPY
|
189,000,000
JPY
|
300,000,000
JPY
|
8,526,000,000
JPY
|
149,000,000
JPY
|
| Purpose of shareholding |
・良好な取引関係の維持発展・検証実施(注)
|
・良好な取引関係の維持発展・検証実施(注)・株式分割
|
・良好な取引関係の維持発展・検証実施(注)
|
・良好な取引関係の維持発展・検証実施(注)・取引先持株会会員
|
・良好な取引関係の維持発展・検証実施(注)・取引先持株会会員
|
・同業界内における関係維持発展に伴う中 長期的な企業価値の向上・検証実施(注)
|
— | — | — | — | — | — |